- A -0.56%
Agilent Technologies, Inc. (NYSE:A) is one of the stocks Jim Cramer recently talked about. Cramer discussed the company’s latest quarter during the episode, as he said:
“Last night, we got a very good quarter from letter A, Agilent Technologies, one of the key arms dealers of the life sciences industry. The company reported a modest top and bottom-line beat. Organic revenue up… very strong, 7.2%. Wall Street was only looking for 5.3%. Management also gave us robust revenue guidance for 2026. Although the earnings guidance was a bit light, but I, we have to examine that, it wasn’t enough to derail the stock. It rallied $3.60 or a little over 2% today. At $157, get this, Agilent’s still down a little more than 20 bucks from its COVID year peak. But it sure feels like this company’s finally gotten its groove back, along with the rest of the life sciences industry.”
A stock market graph. Photo by Alesia Kozik on Pexels
Agilent Technologies, Inc. (NYSE:A) provides instruments, software, and services for life sciences, diagnostics, and chemical analysis, including chromatography, spectroscopy, genomics, and laboratory automation solutions.
While we acknowledge the potential of A as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Terms and Privacy Policy Privacy Dashboard More Info